Search results
Cue Biopharma, Inc. (NASDAQ:CUE) Q3 2023 Earnings Call Transcript
Insider Monkey via Yahoo Singapore Finance· 8 months agoCue Biopharma, Inc. (NASDAQ:CUE) Q3 2023 Earnings Call Transcript November 11, 2023 Operator: Good...
Onconova Therapeutics, Inc. (NASDAQ:ONTX) Q3 2023 Earnings Call Transcript
Insider Monkey via Yahoo Singapore Finance· 8 months agoOnconova Therapeutics, Inc. (NASDAQ:ONTX) Q3 2023 Earnings Call Transcript November 14, 2023...
Gritstone (GRTS) Plummets 58% in a Week: Here's Why
Zacks via Yahoo Singapore Finance· 3 months agoGritstone (GRTS) plunges after a mid-stage study evaluating its personalized cancer vaccine in certain patients with colorectal cancer failed to achieve...
Pharma Stock Roundup: NVO & LLY to Expand Manufacturing Capacity in Europe, & More
Zacks via Yahoo Singapore Finance· 8 months agoEli Lilly (LLY) plans to build a $2.5 billion manufacturing plant in Germany. Novo Nordisk (NVO)...
Ideaya (IDYA) Up on Interim Data from Mid-Stage Eye Cancer Study
Zacks via Yahoo Singapore Finance· 2 years agoIdeaya Biosciences (IDYA) reports positive interim results from its mid-stage study, evaluating...
12 Healthcare Stocks Billionaires Like the Most
Insider Monkey via Yahoo Singapore Finance· 7 months agoIn this article, we will take a look at the 12 healthcare stocks billionaires like the most. To skip our analysis of the recent market trends and...
Novartis Announces Positive Data on Breast Cancer Drug Kisqali
Zacks via Yahoo Singapore Finance· 1 year agoNovartis NVS announced positive data on the breast cancer drug Kisqali (ribociclib) from the...
Zymeworks Inc. (NYSE:ZYME) Q4 2023 Earnings Call Transcript
Insider Monkey via Yahoo Singapore Finance· 4 months agoZymeworks Inc. (NYSE:ZYME) Q4 2023 Earnings Call Transcript March 6, 2024 Zymeworks Inc. beats...
Bristol Myers (BMY) Receives FDA Approval for NSCLC Drug
Zacks via Yahoo Singapore Finance· 8 months agoBristol Myers Squibb BMY announced that the FDA has approved repotrectinib, a TKI targeting ROS1...
Biotech Stock Roundup: PTGX Gains on Study Data, BMRN Faces Setback & More
Zacks via Yahoo Singapore Finance· 1 year agoThe biotech sector was in focus with key pipeline and regulatory updates. Among these, BMRN was down...